undamentalytics Newsletter
Sign in

Alkermes plc. cash flow statement

In fiscal 2025, Alkermes plc.'s operations generated $521m of cash; it spent $40.4m on capital projects, leaving free cash flow of $480m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Mar 20102011Mar 20112012Mar 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations−12−6−214811−40−641999728310221401439521243
Depreciation and amortisation25948—988694991048082797875292781
Stock-based pay142029—609794841051019088941019799120
Capital spending169172234534451699142283848334016
Free cash flow−28−15−19125−23−93−107−3230−194174−17353406480227
Free cash flow after stock pay−42−35−48—−82−191−202−116−76−120−50−14−111252309382107
Share buybacks3—————————————200——
Shares issued————248————————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ALKS vs HALOALKS vs INSMALKS vs MDGLALKS vs MRNA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Alkermes plc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alkermes plc.